Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 302.12M P/E - EPS this Y 27.10% Ern Qtrly Grth -
Income -48.88M Forward P/E -3.24 EPS next Y -57.10% 50D Avg Chg 6.00%
Sales - PEG -0.06 EPS past 5Y - 200D Avg Chg -10.00%
Dividend N/A Price/Book 1.31 EPS next 5Y 23.10% 52W High Chg -63.00%
Recommedations 1.80 Quick Ratio 18.70 Shares Outstanding 51.52M 52W Low Chg 72.00%
Insider Own 2.31% ROA -19.88% Shares Float 38.27M Beta 1.52
Inst Own 84.25% ROE -22.62% Shares Shorted/Prior 1.06M/1.09M Price 6.60
Gross Margin - Profit Margin - Avg. Volume 340,114 Target Price 8.20
Oper. Margin - Earnings Date Nov 7 Volume 140,737 Change 0.00%
About PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.

PMV Pharmaceuticals, Inc. News
11/07/24 PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results
10/23/24 US Penny Stocks To Consider In October 2024
10/23/24 PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial
09/26/24 PMV Pharmaceuticals (NASDAQ:PMVP) Is In A Good Position To Deliver On Growth Plans
08/08/24 PMV Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Progress Update on PYNNACLE Clinical Trial
06/03/24 Here's Why PMV Pharmaceuticals (PMVP) Could be Great Choice for a Bottom Fisher
05/30/24 PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June
05/29/24 Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
05/28/24 Here's Why You Should Buy Acrivon Therapeutics (ACRV) Stock
05/09/24 PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights
03/27/24 PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors
03/18/24 PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer
03/01/24 PMV Pharmaceuticals Inc (PMVP) Reports Full Year 2023 Financial Results
02/29/24 PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights
02/26/24 PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference
01/18/24 PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway
01/05/24 PMV Pharmaceuticals Strengthens Leadership with Key Appointments as Company Advances into Late-Stage Development
PMVP Chatroom

User Image DonCorleone77 Posted - 1 day ago

$PMVP PMV Pharmaceuticals files $200M mixed securities shelf

User Image Bearbonds2 Posted - 1 week ago

$PMVP https://www.investing.com/news/analyst-ratings/oppenheimer-raises-pmvp-rating-to-outperform-sets-stock-target-on-q3-results-93CH-3711578

User Image Bearbonds2 Posted - 1 week ago

$PMVP https://www.tipranks.com/news/the-fly/pmv-pharmaceuticals-upgraded-to-outperform-from-perform-at-oppenheimer?utm_source=markets.businessinsider.com&utm_medium=referral

User Image Big_Dzick Posted - 1 week ago

$PMVP buy and hold. Over 3 soon

User Image Bearbonds2 Posted - 2 weeks ago

$PMVP https://ca.finance.yahoo.com/news/pmv-pharmaceuticals-reports-third-quarter-130000256.html No cash needed until end of 2026. Great management

User Image Bearbonds2 Posted - 2 weeks ago

$PMVP Grinding. Our little guy is grinding again

User Image Bearbonds2 Posted - 2 weeks ago

$PMVP This guy has been behaving so well lately. Not much volume I agree but it looks like a slow grind higher. There’s got to be something good behind these close doors. Holding for sure.

User Image Bearbonds2 Posted - 10/31/24

$PMVP Well well, this little guy is doing great with all the chaos happening in the market. We saw 1.80 last week and holding pretty good around the 1.60 level with decent volume. They might have a surprise for us down the road. Holding strong.

User Image Bearbonds2 Posted - 10/23/24

$PMVP Brutal, don’t be surprised when you read tomorrow that some funds cut their positions. Retail not strong enough to handle selling volume. Back on the wait and see wagon

User Image Bearbonds2 Posted - 10/23/24

$PMVP https://www.stocktitan.net/news/PMVP/pmv-pharmaceuticals-provides-a-progress-update-on-pynnacle-clinical-24neo90g17np.html

User Image PenkeTrading Posted - 10/23/24

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Pmv Pharmaceuticals Inc. Is that bullish or bearish? $PMVP #RsiOverbought #NASDAQ

User Image maizeblue22 Posted - 10/22/24

$PMVP looking good

User Image Bearbonds2 Posted - 10/22/24

$PMVP Something is cooking here. I believe in the administration of this company. Matter of time before they come up with surprises.

User Image Bearbonds2 Posted - 10/22/24

$PMVP Slow grinding back up. I like it. Volume picking up as well. Holding

User Image TheMFBearKillla Posted - 1 month ago

$PMVP hmmm

User Image insiderbuyingselling Posted - 2 months ago

$PMVP new insider selling: 2891 shares. http://insiderbuyingselling.com/?t=PMVP

User Image Stock_Titan Posted - 3 months ago

$PMVP PMV Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Progress Update on PYNNACLE Clinical Trial https://www.stocktitan.net/news/PMVP/pmv-pharmaceuticals-reports-second-quarter-2024-financial-results-1zl08g49ezp3.html

User Image jasonlin280 Posted - 3 months ago

$PMVP it’s getting near

User Image NVDAMillionaire Posted - 3 months ago

$PMVP PMV Pharmaceuticals, Inc. (NASDAQ:PMVP): Pioneering Precision Oncology with Promising Pipeline http://beyondspx.com/2024/08/02/pmv-pharmaceuticals-inc-nasdaqpmvp-pioneering-precision-oncology-with-promising-pipeline/

User Image Travelling Posted - 4 months ago

$PMVP $mrinvestorpro called this to double at 2.18 - ugh.

User Image Papawu99 Posted - 4 months ago

$PMVP was hoping this would actually be a break through for cancer but it seems still a long ways before we get an answer

User Image jasonlin280 Posted - 4 months ago

$PMVP this stock is doom

User Image Stock_Titan Posted - 05/29/24

$PMVP Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator https://www.stocktitan.net/news/PMVP/foundation-medicine-and-pmv-pharma-announce-collaboration-to-develop-nn4bm7b1gfwh.html

User Image valorallure Posted - 6 months ago

$PMVP I like the value here. The ADC market is hot! The recent biotech conference in San Francisco hosted by JP Morgan Chase was all about antibody-drug conjugates. The company recently reduced workforce by 30% and sells far below net cash. Even with two more years of cash burn, the company almost sells below net cash. I also like that Orbimed is the largest shareholder. Kinnate was a biotech focused on ADC who ended up getting bought out.

User Image BabyGangsterAX Posted - 6 months ago

$PMVP this is another good one. Load between 175-2.20 and hold until it is up above 100% or more. High hope on this shix.. Remember ! Bull Market is almost coming.. Load cheapies and hold.. wait for the Run in June - October

User Image Bearbonds2 Posted - 6 months ago

$PMVP

User Image Bearbonds2 Posted - 6 months ago

$PMVP https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3Lm1hcmtldGJlYXQuY29tL2luc3RhbnQtYWxlcnRzL25hc2RhcS1wbXZwLXJlaXRlcmF0ZWQtcmF0aW5nLTIwMjQtMDUtMTQv0gEA

User Image Bearbonds2 Posted - 6 months ago

$PMVP No way I’m selling with all the strong buy recommendations everywhere.

User Image Money_never_sleep Posted - 6 months ago

$PMVP

User Image G101SPM Posted - 6 months ago

$PMVP $2.12 bid. DAC (dollar average cost) (2) $1.635 last $1.54 (2.16.25. EXIT $4.00. UPDATE: PMV Pharmaceuticals (PMVP) initiated with a Buy at Craig Hallum; tgt $6.

Analyst Ratings
HC Wainwright & Co. Buy Aug 20, 24
HC Wainwright & Co. Buy May 30, 24
HC Wainwright & Co. Buy May 14, 24
Craig-Hallum Buy May 13, 24
Jefferies Buy Apr 12, 24
HC Wainwright & Co. Buy Mar 7, 24
Ladenburg Thalmann Buy Dec 27, 23
HC Wainwright & Co. Buy Oct 16, 23
HC Wainwright & Co. Buy Aug 11, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
ORBIMED ADVISORS LLC 10% Owner 10% Owner Nov 22 Sell 2.23 87,786 195,763 11/24/23
Mack David Henry President and CEO President and CEO Aug 07 Option 0.53 85,500 45,315 165,470 08/08/23
Mack David Henry President and CEO President and CEO Apr 27 Option 0.53 33,000 17,490 79,970 04/29/22
ORBIMED ADVISORS LLC 10% Owner 10% Owner Mar 29 Sell 21.69 474,500 10,291,905 03/31/22
Mack David Henry President and CEO President and CEO Dec 15 Option 0.53 9,000 4,770 26,970 12/16/21